Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.210
-0.040 (-3.20%)
Apr 3, 2025, 2:45 PM EDT - Market open

Ikena Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
58799596450-
Upgrade
Market Cap Growth
-16.75%-16.75%-1.43%-78.58%--
Upgrade
Enterprise Value
-57-50-59-72212-
Upgrade
Last Close Price
1.251.641.972.6612.54-
Upgrade
PS Ratio
-10.386.1814.53-
Upgrade
PB Ratio
0.480.630.560.662.17-
Upgrade
P/TBV Ratio
0.630.630.560.662.17-
Upgrade
EV/Sales Ratio
---6.83-
Upgrade
Debt / Equity Ratio
0.060.060.060.040.030.00
Upgrade
Asset Turnover
--0.050.070.150.07
Upgrade
Quick Ratio
11.5411.5412.357.308.545.74
Upgrade
Current Ratio
11.8011.8012.587.448.705.86
Upgrade
Return on Equity (ROE)
-33.30%-33.30%-43.04%-38.76%-21.81%-72.35%
Upgrade
Return on Assets (ROA)
-20.44%-20.44%-25.87%-21.09%-10.25%-21.88%
Upgrade
Return on Capital (ROIC)
-21.72%-21.72%-28.30%-24.12%-13.34%-45.42%
Upgrade
Earnings Yield
-81.62%-62.21%-71.70%-71.30%-7.58%-
Upgrade
FCF Yield
-76.26%-58.13%-84.31%-78.32%-13.77%-
Upgrade
Buyback Yield / Dilution
-15.63%-15.63%-15.33%-29.32%-911.88%-4.43%
Upgrade
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q